Header Logo

Connection

Barish Edil to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications Barish Edil has written about Clinical Trials, Phase I as Topic.
Barish Edil
Connection Strength
0.029
Clinical Trials, Phase I as Topic
  1. A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer. Ann Surg Oncol. 2014 Nov; 21(12):3931-7.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.